Validation of a New Method for the Monitoring of Environmental Benzene at Low Concentration Using the Needle Trap Device

Abstract

a headache, drowsiness, nausea, dizziness, confusion, severe damage to the kidney, the liver and the nervous system, and the irritation of the nose were reported [12-15]. Acute exposure through inhalation can cause illnesses such as headaches, drowsiness, dizziness, and irritation of the skin, whereas chronic exposure may cause more severe ailments, including aplastic anemia and leukemia at the occupational settings [16,17]. Due to its potential health threats, in according to the International Agency for Research on Cancer (IARC) classified, benzene is a group 1 human carcinogen [18].

Benzene: A critical review on measurement methodology, certified reference material, exposure limits with its impact on human health and mitigation strategies

“…Sousa et al studied benzene levels in indoor and outdoor environments using the GC-FID technique, with tandem mass spectrometric detection (MS/MS) used to confirm benzene in ambient air [ 96 ]. Bayatian et al reported a new method involving a sampling needle trap device (NTD) and analysis performed using GC-FID, with benzene level measured in the range of 0.15 to 1.2 ppm [ 97 ]. Kumari et al reported benzene concentrations at fuel stations and traffic intersections, with sampling conducted using charcoal sorbent tubes and subsequent analysis using GC-FID [ 2 - 3 ].…”